These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8035486)

  • 21. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.
    Yang C; Compans RW
    J Virol; 1996 Jan; 70(1):248-54. PubMed ID: 8523533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
    Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
    J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin.
    Ikuta K; Luftig RB
    Virology; 1986 Oct; 154(1):195-206. PubMed ID: 3489314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance.
    Granowitz C; Colicelli J; Goff SP
    Virology; 1991 Aug; 183(2):545-54. PubMed ID: 1853560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational analysis of interactions between the Gag precursor proteins of murine leukemia viruses.
    Alin K; Goff SP
    Virology; 1996 Feb; 216(2):418-24. PubMed ID: 8607272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ubiquitination of HIV-1 and MuLV Gag.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Schubert U
    Virology; 2000 Dec; 278(1):111-21. PubMed ID: 11112487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein.
    Wang MQ; Goff SP
    J Virol; 2003 Mar; 77(5):3339-44. PubMed ID: 12584360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus.
    Thomas A; Roth MJ
    Virology; 1995 Aug; 211(1):285-9. PubMed ID: 7645222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electron-microscopic immunocytochemical study of the intracellular transport of the viral glycoproteins in ts1, a mutant of Moloney murine leukemia virus.
    Roussev R; Shikova E; Sovová V; Stokrová J; Alexandrov M
    Folia Biol (Praha); 1998; 44(4):123-6. PubMed ID: 10732700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the psi-gag-PR region.
    Richardson J; Corbin A; Pozo F; Orsoni S; Sitbon M
    J Virol; 1993 Sep; 67(9):5478-86. PubMed ID: 8350407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spike protein-nucleocapsid interactions drive the budding of alphaviruses.
    Suomalainen M; Liljeström P; Garoff H
    J Virol; 1992 Aug; 66(8):4737-47. PubMed ID: 1629953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
    Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
    J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus.
    Han JY; Cannon PM; Lai KM; Zhao Y; Eiden MV; Anderson WF
    J Virol; 1997 Nov; 71(11):8103-8. PubMed ID: 9343159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assembly and composition of intracellular particles formed by Moloney murine leukemia virus.
    Hansen M; Jelinek L; Jones RS; Stegeman-Olsen J; Barklis E
    J Virol; 1993 Sep; 67(9):5163-74. PubMed ID: 8350394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.
    Denesvre C; Carrington C; Corbin A; Takeuchi Y; Cosset FL; Schulz T; Sitbon M; Sonigo P
    J Virol; 1996 Jul; 70(7):4380-6. PubMed ID: 8676461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
    Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
    J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores.
    Auerbach MR; Brown KR; Kaplan A; de Las Nueces D; Singh IR
    J Virol; 2006 Mar; 80(6):2884-93. PubMed ID: 16501097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atomic force microscopy investigation of wild-type Moloney murine leukemia virus particles and virus particles lacking the envelope protein.
    Kuznetsov YG; Low A; Fan H; McPherson A
    Virology; 2004 Jun; 323(2):189-96. PubMed ID: 15193915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein.
    McDermott J; Karanjia S; Love Z; Barklis E
    Virology; 2000 Mar; 269(1):190-200. PubMed ID: 10725211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.